BO
GILD icon

Bank OZK’s Gilead Sciences GILD Stock Holding History

Bank OZK’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,165
Closed -$253K – 121
2015
Q2 		$253K Sell
2,165
-30
-1% -$3.28K 0.09% 110
2015
Q1 		$215K Sell
2,195
-935
-30% -$94.9K 0.08% 121
2014
Q4 		$295K Sell
3,130
-47
-1% -$4.86K 0.1% 104
2014
Q3 		$339K Buy
3,177
+9
+0.3% +$881 0.13% 94
2014
Q2 		$263K Buy
+3,168
New +$247K 0.09% 108

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank OZK's GILD Position: Q3 2015 in Review

Bank OZK sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 2,165 shares — an estimated $253K sold.

Bank OZK first reported a position in GILD in Q2 2014 and held it in 5 quarters. The position peaked at $339K in Q3 2014. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Bank OZK reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Bank OZK sold 2,165 Gilead Sciences shares in Q3 2015, an estimated $253K.
  • Bank OZK first reported a position in Gilead Sciences in Q2 2014 and held it in 5 quarters.
  • Bank OZK's Gilead Sciences position peaked at $339K in Q3 2014.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Bank OZK's 13F filing for Q3 2015, filed 22 Oct 2015.